Samrudhi Kisan Biotek Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 03-12-2024
- Paid Up Capital ₹ 0.66 M
as on 03-12-2024
- Company Age 9 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.26 Cr
as on 03-12-2024
- Revenue 39.33%
(FY 2020)
- Profit 50.87%
(FY 2020)
- Ebitda 98.83%
(FY 2020)
- Net Worth 58.14%
(FY 2020)
- Total Assets -14.29%
(FY 2020)
About Samrudhi Kisan Biotek
The Company is engaged in the Environment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.66 M.
The company currently has active open charges totaling ₹7.26 Cr.
Pitchaiah Pelapudi, Sajja Rao, and Hari Jagarlamudi serve as directors at the Company.
- CIN/LLPIN
U01407TG2015PTC097994
- Company No.
097994
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Mar 2015
- Date of AGM
21 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Samrudhi Kisan Biotek?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pitchaiah Pelapudi  | Director | 18-Feb-2017 | Current |
| Sajja Rao | Director | 14-Aug-2019 | Current |
| Hari Jagarlamudi | Director | 14-Aug-2019 | Current |
Financial Performance of Samrudhi Kisan Biotek.
Samrudhi Kisan Biotek Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 39.33% increase. The company also saw a substantial improvement in profitability, with a 50.87% increase in profit. The company's net worth Soared by an impressive increase of 58.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Samrudhi Kisan Biotek?
In 2020, Samrudhi Kisan Biotek had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Sparta Agritech Private LimitedActive 8 years 9 months
Pitchaiah Pelapudi, Sajja Rao and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Mar 2024 | ₹7.00 Cr | Open |
Hdfc Bank Limited Creation Date: 19 May 2023 | ₹1.91 M | Open |
Hdfc Bank Limited Creation Date: 12 May 2023 | ₹0.71 M | Open |
How Many Employees Work at Samrudhi Kisan Biotek?
Samrudhi Kisan Biotek has a workforce of 13 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Samrudhi Kisan Biotek, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Samrudhi Kisan Biotek's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
